Patents by Inventor Marc Ouellette

Marc Ouellette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060263810
    Abstract: DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample DNA from (i) any bacterium, (ii) the species Streptococcus agalactiae, Staphylococcus saprophyticus, Enterococcus faecium, Neisseria meningitidis, Listeria monocytogenes and Candida albicans, and (iii) any species of the genera Streptococcus, Staphylococcus, Enterococcus, Neisseria and Candida are disclosed. DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample antibiotic resistance genes selected from the group consisting of blatem, blarob, blashv, blaoxa, blaZ, aadB, aacC1, aacC2, aacC3, aacA4, aac6?-IIa, ermA, ermB, ermC, mecA, vanA, vanB, vanC, satA, aac(6?)-aph(2?), aad(6), vat, vga, msrA, sul and int are also disclosed. The above microbial species, genera and resistance genes are all clinically relevant and commonly encountered in a variety of clinical specimens.
    Type: Application
    Filed: May 2, 2006
    Publication date: November 23, 2006
    Inventors: Michel Bergeron, Francois Picard, Marc Ouellette, Paul Roy
  • Patent number: 7055722
    Abstract: A spray bottle having a screw neck to which a manual trigger type spray dispenser having a dependent flexible suction tube can be secured. The bottle is provided with a vertical internal wall to divide it into two interconnecting compartments, and the free end of the suction tube is directed into the smaller of the two. A substantially horizontal internal wall is also provided to form a second wall of the smaller compartment to facilitate retention of liquid therein when the bottle is inverted.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: June 6, 2006
    Inventor: Marc Ouellette
  • Publication number: 20050042606
    Abstract: The present invention relates to DNA-based methods for universal bacterial detection, for specific detection of the common bacterial pathogens Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Staphylococcus saprophyticus, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis as well as for specific detection of commonly encountered and clinically relevant bacterial antibiotic resistance genes directly from clinical specimens or, alternatively, from a bacterial colony. The above bacterial species can account for as much as 80% of bacterial pathogens isolated in routine microbiology laboratories.
    Type: Application
    Filed: April 11, 2002
    Publication date: February 24, 2005
    Inventors: Michel Bergeron, Marc Ouellette, Paul Roy
  • Patent number: 6855537
    Abstract: Strains of Leishmania and other macrophage-infecting parasites are provided which express the GM-CSF gene which are useful in treating hosts infected by the parasite and in protecting hosts against disease caused by infection of hosts by parasites. The parasites are reduced in their ability to infect or survive in macrophages and hence are attenuated. At least one gene of the parasite contributing to the virulence thereto may be functionally disabled. The attenuated strains may be used for administration to a host (a) to treat a host infected by Leishmania or (b) to confer protection against disease caused by a virulent Leishmania strain, or as a diagnostic reagent.
    Type: Grant
    Filed: September 16, 1997
    Date of Patent: February 15, 2005
    Assignee: Aventis Pasteur Limited
    Inventors: Barbara Papadopoulu, Marc Ouellette, Martin Olivier
  • Publication number: 20040185478
    Abstract: DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample DNA from (i) any bacterium, (ii) the species Streptococcus agalactiae, Staphylococcus saprophyticus, Enterococcus faecium, Neisseria meningitidis, Listeria monocytogenes and Candida albicans, and (iii) any species of the genera Streptococcus, Staphylococcus, Enterococcus, Neisseria and Candida are disclosed. DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample antibiotic resistance genes selected from the group consisting of blatem, blarob, blashv, blaoxa, blaZ, aadB, aacC1, aacC2, aacC3, aacA4, aac6′-lla, ermA, ermB, ermC, mecA, vanA, vanB, vanC, satA, aac(6′)-aph(2″), aad(6′), vat, vga, msrA, sul and int are also disclosed. The above microbial species, genera and resistance genes are all clinically relevant and commonly encountered in a variety of clinical specimens.
    Type: Application
    Filed: January 7, 2004
    Publication date: September 23, 2004
    Inventors: Michel G. Bergeron, Francois J. Picard, Marc Ouellette, Paul H. Roy
  • Publication number: 20040112922
    Abstract: A spray bottle having a screw neck to which a manual trigger type spray dispenser having a dependent flexible suction tube can be secured. The bottle is provided with a vertical internal wall to divide it into two interconnecting compartments, and the free end of the suction tube is directed into the smaller of the two. A substantially horizontal internal wall is also provided to form a second wall of the smaller compartment to facilitate retention of liquid therein when the bottle is inverted.
    Type: Application
    Filed: November 25, 2003
    Publication date: June 17, 2004
    Inventor: Marc Ouellette
  • Patent number: 6652847
    Abstract: Attenuated strains of Leishmania are provided in which at least one gene contributing to virulence of the strain and expressed in both the promastigote and amastigote forms of the strain is functionally disabled, such as, by deleting at least a portion of the gene or by mutagenesis of the gene. The attenuated strain may be used for administration to a host to confer protection against disease caused by a virulent Leishmania strain or as a diagnostic reagent.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: November 25, 2003
    Assignee: Universite Laval
    Inventors: Barbara Papadopoulou, Marc Ouellette, Martin Olivier
  • Publication number: 20030180733
    Abstract: The present invention relates to DNA-based methods for universal bacterial detection, for specific detection of the common bacterial pathogens Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Staphylococcus saprophyticus, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis as well as for specific detection of commonly encountered and clinically relevant bacterial antibiotic resistance genes directly from clinical specimens or, alternatively, from a bacterial colony. The above bacterial species can account for as much as 80% of bacterial pathogens isolated in routine microbiology laboratories.
    Type: Application
    Filed: April 11, 2002
    Publication date: September 25, 2003
    Inventors: Michel G. Bergeron, Marc Ouellette, Paul H. Roy
  • Patent number: 6562132
    Abstract: An improved mechanical arrangement controls the introduction of silicon particles into an EFG (Edge-defined Film-fed Growth) crucible/die unit for melt replenishment during a crystal growth run. A feeder unit injects silicon particles upwardly through a center hub of the crucible/die unit and the mechanical arrangement intercepts the injected particles and directs them so that they drop into the melt in a selected region of the crucible and at velocity which reduces splashing, whereby to reduce the likelihood of interruption of the growth process due to formation of a solid mass of silicon on the center hub and adjoining components. The invention also comprises use of a Faraday ring to alter the ratio of the electrical currents flowing through primary and secondary induction heating coils that heat the crucible die unit and the mechanical arrangement.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: May 13, 2003
    Assignee: ASE Americas, Inc.
    Inventors: Brian H. Mackintosh, Marc Ouellette
  • Publication number: 20030049636
    Abstract: DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample DNA from (i) any bacterium, (ii) the species Streptococcus agalactiae, Staphylococcus saprophyticus, Enterococcus faecium, Neisseria meningitidis, Listeria monocytogenes and Candida albicans, and (iii) any species of the genera Streptococcus, Staphylococcus, Enterococcus, Neisseria and Candida are disclosed. DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample antibiotic resistance genes selected from the group consisting of blatem, blarob, blashv, blaoxa, blaZ, aadB, aacC1, aacC2, aacC3, aacA4, aac6′-lla, ermA, ermB, ermC, mecA, vanA, vanB, vanC, satA, aac(6′)-aph(2″), aad(6′), vat, vga, msrA, sul and int are also disclosed. The above microbial species, genera and resistance genes are all clinically relevant and commonly encountered in a variety of clinical specimens.
    Type: Application
    Filed: November 20, 2001
    Publication date: March 13, 2003
    Inventors: Michel G. Bergeron, Francois J. Picard, Marc Ouellette, Paul H. Roy
  • Publication number: 20020144649
    Abstract: An improved mechanical arrangement controls the introduction of silicon particles into an EFG (Edge-defined Film-fed Growth) crucible/die unit for melt replenishment during a crystal growth run. A feeder unit injects silicon particles upwardly through a center hub of the crucible/die unit and the mechanical arrangement intercepts the injected particles and directs them so that they drop into the melt in a selected region of the crucible and at velocity which reduces splashing, whereby to reduce the likelihood of interruption of the growth process due to formation of a solid mass of silicon on the center hub and adjoining components. The invention also comprises use of a Faraday ring to alter the ratio of the electrical currents flowing through primary and secondary induction heating coils that heat the crucible die unit and the mechanical arrangement.
    Type: Application
    Filed: April 4, 2001
    Publication date: October 10, 2002
    Applicant: ASE Americas, Inc.
    Inventors: Brian H. Mackintosh, Marc Ouellette
  • Patent number: 6426203
    Abstract: Attenuated strains of Leishmania are provided in which at least one gene contributing to virulence of the strain and expressed in both the promastigote and amastigote forms of the strain is functionally disabled, such as, by deleting at least a portion of the gene or by mutagenesis of the gene. The attenuated strain may be used for administration to a host to confer protection against disease caused by a virulent Leishmania strain or as a diagnostic reagent.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: July 30, 2002
    Assignee: Universite Laval
    Inventors: Barbara Papadopoulou, Marc Ouellette, Martin Olivier
  • Patent number: 6403081
    Abstract: Attenuated strains of Leishmania are provided in which at least one gene contributing to virulence of the strain and expressed in both the promastigote and amastigote forms of the strain is functionally disabled, such as, by deleting at least a portion of the gene or by mutagenesis of the gene. The attenuated strain may be used for administration to a host to confer protection against disease caused by a virulent Leishmania strain or as a diagnostic reagent.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: June 11, 2002
    Assignee: Aventis Pasteur Limited
    Inventors: Barbara Papadopoulou, Marc Ouellette, Martin Olivier
  • Patent number: 6331304
    Abstract: Strains of Leishmanda and other macrophage-infecting parasites are provided which express the GM-CSF gene which are useful in treating hosts infected by the parasite and in protecting hosts against disease caused by infection of hosts by parasites. The parasites are reduced in their ability to infect or survive in macrophages and hence are attenuated. At least one gene of the parasite contributing to the virulence thereto may be functionally disabled. The attenuated strains may be used for administration to a host (a) to treat a host infected by Leishmania or (b) to confer protection against disease caused by a virulent Leishmania strain, or as a diagnostic reagent.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: December 18, 2001
    Assignee: Universite Laval
    Inventors: Barbara Papadopoulou, Marc Ouellette, Martin Olivier
  • Patent number: 6295993
    Abstract: A method and apparatus for highlighting hair is described. A frame, having a pair of parallel rods and a scalp engaging member mounted therebetween at the lower end, has a guide tube mounted parallel to the rods adjacent the upper end thereof, and a spring loaded plunger having a double prong at the lower end is mounted through the guide tube and concentric therewith. A treatment tube, usually made of aluminum foil, is placed over the guide tube and the apparatus is placed against the scalp. The spring-loaded plunger is operated to extend the prongs, which encircle selected strands of hair, and then released to draw the hair into the guide tube. The apparatus is then removed from the scalp and the treatment tube is pushed off the guide tube so as to contain the selected strands of hair within it. The lower end is then crimped around the hair, treatment solution is added and the top is crimped. After a selected treatment time the treatment tube is removed.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 2, 2001
    Inventor: Marc Ouellette
  • Patent number: 6162638
    Abstract: Attenuated strains of Leishmania are provided in which at least one gene contributing to virulence of the strain and expressed in both the promastigote and amastigote forms of the strain is functionally disabled, such as, by deleting at least a portion of the gene or by mutagenesis of the gene. The attenuated strain may be used for administration to a host to confer protection against disease caused by a virulent Leishmania strain or as a diagnostic reagent.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: December 19, 2000
    Assignee: Universite Laval
    Inventors: Barbara Papadopoulou, Marc Ouellette, Martin Olivier
  • Patent number: 6001564
    Abstract: The present invention relates to DNA-based methods for universal bacterial detection, for specific detection of the common bacterial pathogens Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Staphylococcus saprophyticus, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis as well as for specific detection of commonly encountered and clinically relevant bacterial antibiotic resistance genes directly from clinical specimens or, alternatively, from a bacterial colony. The above bacterial species can account for as much as 80% of bacterial pathogens isolated in routine microbiology laboratories.
    Type: Grant
    Filed: September 11, 1995
    Date of Patent: December 14, 1999
    Assignee: Infectio Diagnostic, Inc.
    Inventors: Michel G. Bergeron, Marc Ouellette, Paul H. Roy
  • Patent number: 5994066
    Abstract: The present invention relates to a method for universal detection of bacteria in biological samples and for specific detection of Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, Pseudomonas aeruginosa, Proteus mirabilis, Staphylococcus saprophyticus, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in urine or any other biological samples, said method comprising denaturation of bacterial DNA to single stranded form and either fixing it on a support or leaving it in solution, contacting said single stranded genetic material with a labeled probe selected from the group consisting of i) fragments of chromosomal DNA of the above-mentioned bacteria and ii) synthetic oligonucleotides whose sequences are derived either from the said fragments of chromosomal DNAs or from sequences available in data banks, all (i and ii) probes being capable to hybridize specifically to their chromosomal DNA or, in case of universal probes, to any bacterial chromosomal DNA.
    Type: Grant
    Filed: November 4, 1996
    Date of Patent: November 30, 1999
    Assignee: Infectio Diagnostic, Inc.
    Inventors: Michel G. Bergeron, Fran.cedilla.ois J. Picard, Marc Ouellette, Paul H. Roy